ROS Generative Black Phosphorus-Tamoxifen Nanosheets for Targeted Endocrine-Sonodynamic Synergistic Breast Cancer Therapy

INTRODUCTION: Tamoxifen (TAM) has proven to be a therapeutic breakthrough to reduce mortality and recurrence in estrogen receptor-positive (ER+) breast cancer patients. However, the application of TAM exhibits low bioavailability, off-target toxicity, instinct and acquired TAM resistance. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Chen, Weijian, Du, Wenxiang, Zhang, Hongjie, Ilmer, Matthias, Song, Lei, Hu, Yuan, Ma, Xiaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182776/
https://www.ncbi.nlm.nih.gov/pubmed/37192893
http://dx.doi.org/10.2147/IJN.S406627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182776/
https://www.ncbi.nlm.nih.gov/pubmed/37192893
http://dx.doi.org/10.2147/IJN.S406627

Ejemplares similares